Aurinia Pharmaceuticals Inc (AUPH)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AUPH market cap is 1.25B. The company's latest EPS is USD -0.5456 and P/E is -16.07.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 44.83M | 54.52M | 45.1M | 54.43M | 57.48M |
| Operating Income | -16.46M | -13.62M | -28.98M | -13.25M | -1.51M |
| Net Income | -11.49M | -13.45M | -26.88M | -10.75M | 722k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 372k | 50.12M | 45.61M | 135.55M | 175.51M |
| Operating Income | -85.3M | -104.29M | -180.74M | -111.47M | -91.69M |
| Net Income | -123.85M | -102.68M | -180.97M | -108.18M | -78.02M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 548.9M | 555.01M | 548.06M | 516.63M | 523.53M |
| Total Liabilities | 156.61M | 163.14M | 170.11M | 157.16M | 158.91M |
| Total Equity | 392.29M | 391.88M | 377.95M | 359.48M | 364.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 326.68M | 463.66M | 543.37M | 470.86M | 548.06M |
| Total Liabilities | 53.17M | 55.91M | 64.28M | 65.43M | 170.11M |
| Total Equity | 273.52M | 407.75M | 479.09M | 405.44M | 377.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -34.5M | -47.77M | -33.46M | -18.6M | -2.76M |
| Investing | 19.25M | -449k | -6.71M | 49.23M | 10.61M |
| Financing | 2.78M | 447k | -5.13M | -15.05M | -23.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -63.46M | -69.86M | -157.69M | -79.53M | -33.46M |
| Investing | 7.78M | -158.19M | -103.87M | -60.63M | -6.71M |
| Financing | 243.73M | 194.38M | 221.11M | 2.43M | -5.13M |
| Market Cap | 1.25B |
| Price to Earnings Ratio | -16.07 |
| Price to Sales Ratio | 7.15 |
| Price to Cash Ratio | 25.66 |
| Price to Book Ratio | 3.32 |
| Dividend Yield | - |
| Shares Outstanding | 142.99M |
| Average Volume (1 week) | 1.52M |
| Average Volume (1 Month) | 1.49M |
| 52 Week Change | -1.24% |
| 52 Week High | 9.74 |
| 52 Week Low | 4.71 |
| Spread (Intraday) | 0.12 (1.37%) |
| Company Name | Aurinia Pharmaceuticals Inc |
| Address |
1203-4464 markham street victoria, british columbia V8Z 7X8 |
| Website | https://www.auriniapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
